PCM Healthcare sold to Cogora
Cogora, the media and marketing services group, has announced the acquisition of PCM Healthcare, a leading medical education and communications agency. PCM Healthcare was advised by BCMS throughout the transaction, in a deal that created one of the UK’s largest independent healthcare agencies.
PCM Healthcare pioneered novel approaches to deliver healthcare communications and non-promotional medical education that have measurable impact on patient care standards for a range of clients including Novartis, Gilead and Indivior.
“We were immediately impressed with BCMS’ knowledge of our industry and the marketplace” – Rob Miller, PCM Healthcare
Commenting on the deal, Dr Alisa Pearlstone, co-founder of PCM Healthcare, said: “PCM Healthcare has grown significantly in recent years on the back of our clear commitment to delivering innovative techniques and meaningful outcomes for our clients. Our partnership with Cogora creates an excellent synergy and promises a significant boost to the PCM Healthcare offering.”
On working with BCMS, co-founder Rob Miller added: “When we first met with BCMS, we were immediately impressed with their knowledge of our industry and the marketplace, and coupled with their obvious expertise in how to position and sell our business, it was a very easy decision for us to engage with them.
“Selling a business is no mean feat, but with BCMS on-board, they made the whole process considerably less stressful thanks to their knowledgeable, dedicated and supportive team who were with us every step of the way – we would thoroughly recommend them if you are considering selling your business.”
Deal insights
Cogora’s media brands include Pulse, Nursing in Practice, The Commissioning Review and Hospital Pharmacy Europe, while the company’s marketing services arm delivers research, strategy and campaigns for its clients.
Cogora Chief Executive John Pettifor commented: “Though we started life as a ‘traditional’ media company, we’ve also been operating in the agency space for some time now and we’ve been looking to build the size of the group in this area.
“We identified PCM right at the very beginning of that journey as a potential acquisition that would bring the very highest levels of technical expertise and clinical knowledge to the group, as well as broaden the geographic scope of our operations and bring their leadership position within European Continuing Medical Education.”
